Evidence map›Paper›PMID 34198798›Full record

ArticleCancers2021

Lung, Breast and Colorectal Cancer Incidence by Socioeconomic Status in Spain: A Population-Based Multilevel Study.

Daniel Redondo-Sánchez, Rafael Marcos-Gragera, Marià Carulla, Arantza Lopez de Munain, Consol Sabater Gregori, Rosario Jimenez Chillarón, Marcela Guevara, Olivier Nuñez, Pablo Fernández-Navarro, María-José Sánchez and 1 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  9. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  10. Article
  11. Article
  12. Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona.International journal of environmental research and public health · 2021
    Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel Redondo-SánchezNon-Communicable Disease and Cancer Epidemiology Group, Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Calle Doctor Azpitarte 4, 18012 Granada, Spain.ORCID 0000-0001-9986-915X
Rafael Marcos-GrageraConsortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-9824-3657
Marià CarullaTarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Av. Josep Laporte, 2, 43204 Reus, Spain.ORCID 0000-0001-8562-117X
Arantza Lopez de MunainBasque Country Cancer Registry, Health Department, Basque Government, Calle Donostia, 1, 01010 Vitoria-Gasteiz, Spain.ORCID 0000-0001-6820-9124
Consol Sabater GregoriCastellón Cancer Registry, Comunitat Valenciana Cancer Information System, Department of Health, Autonomous Government of Comunitat Valenciana, Av. De Cataluña, 21, 46020 València, Spain.
Rosario Jimenez ChillarónCuenca Cancer Registry, Department of Public Health, Autonomous Government of Castilla la Mancha, Calle de las Torres, 43, 16071 Cuenca, Spain.
Marcela GuevaraConsortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-9242-6364
Olivier NuñezConsortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.ORCID 0000-0002-6651-8879
Pablo Fernández-NavarroConsortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-9427-2581
María-José SánchezNon-Communicable Disease and Cancer Epidemiology Group, Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Calle Doctor Azpitarte 4, 18012 Granada, Spain.ORCID 0000-0003-4817-0757
Miguel Angel Luque-FernandezNon-Communicable Disease and Cancer Epidemiology Group, Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Calle Doctor Azpitarte 4, 18012 Granada, Spain.ORCID 0000-0001-6683-5164

Funding

Asociación Española Contra el Cáncer (AECC) PROYE20023SÁNCCancer Epidemiological Surveillance Subprogram (VICA) from the CIBER Epidemiologia y Salud Pública (CIBERESP) from the Instituto de Salud Carlos IIIInstituto de Salud Carlos III (ISCIII) PI18/01593La Caixa FoundationSpanish National Health Institute Carlos III Miguel Servet-I Investigator grant/award CP17/00206-EU-FEDER
6 · The paper itself

Abstract

Socioeconomic inequalities in cancer incidence are not well documented in southern Europe. We aim to study the association between socioeconomic status (SES) and colorectal, lung, and breast cancer incidence in Spain. We conducted a multilevel study using data from Spanish population-based cancer registries, including incident cases diagnosed for the period 2010-2013 in nine Spanish provinces. We used Poisson mixed-effects models, including the census tract as a random intercept, to derive cancer incidence rate ratios by SES, adjusted for age and calendar year. Male adults with the lowest SES, compared to those with the highest SES, showed weak evidence of being at increased risk of lung cancer (risk ratio (RR): 1.18, 95% CI: 0.94-1.46) but showed moderate evidence of being at reduced risk of colorectal cancer (RR: 0.84, 95% CI: 0.74-0.97). Female adults with the lowest SES, compared to those with the highest SES, showed strong evidence of lower breast cancer incidence with 24% decreased risk (RR: 0.76, 95% CI: 0.68-0.85). Among females, we did not find evidence of an association between SES and lung or colorectal cancer. The associations found between SES and cancer incidence in Spain are consistent with those obtained in other European countries.

Indexed as

breast cancercolorectal cancerepidemiologylung cancerpopulation-based studysocioeconomic inequalities

Identifiers

PMID34198798
PMCPMC8201149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.